Revenue
Q3.24
Q3.25
CS DIAGNOSTICS CORP. (CSDX)
Price—Loading quote
Net income
Q3.25
Free cash flow
No reported data
Total cash / debt
CashTotal debt
Q3.25
Financial statements
| Q3.25 | Q3.24 | |
|---|---|---|
| Revenue | $23,050 | $7,964 |
| Research & development | $0 | — |
| Operating expenses | $23,232 | $7,428 |
| Operating income | −$182 | $536 |
| Net income | −$182 | — |
| Basic EPSper diluted share | $0.00 | $0.00 |
| Diluted EPSper diluted share | $0.00 | $0.00 |